Chondrosarcoma: biology, genetics, and epigenetics.
Chow WA.
F1000Res. 2018 Nov 20;7:F1000 Faculty Rev-1826. doi: 10.12688/f1000research.15953.1. eCollection 2018.
Biomarkers of chondrosarcoma.
Jeong W, Kim HJ.
J Clin Pathol. 2018 Jul;71(7):579-583. doi: 10.1136/jclinpath-2018-205071. Epub 2018 Mar 28.
Chondrosarcoma.
Healey JH, Lane JM.
Clin Orthop Relat Res. 1986 Mar;(204):119-29.
MRI differentiation of low-grade from high-grade appendicular chondrosarcoma.
Douis H, Singh L, Saifuddin A.
Eur Radiol. 2014 Jan;24(1):232-40. doi: 10.1007/s00330-013-3003-y. Epub 2013 Sep 10.
Malignant Cartilage-Forming Tumors.
Hameed M.
Surg Pathol Clin. 2021 Dec;14(4):605-617. doi: 10.1016/j.path.2021.06.005. Epub 2021 Oct 7.
Tracheal chondrosarcoma.
Mendonça V, Jorge M, Monteiro-Grillo I, Palhano MJ, Feijó S.
Clin Transl Oncol. 2010 Aug;12(8):576-80. doi: 10.1007/s12094-010-0557-x.
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
Tlemsani C, Larousserie F, De Percin S, Audard V, Hadjadj D, Chen J, Biau D, Anract P, Terris B, Goldwasser F, Pasmant E, Boudou-Rouquette P.
Int J Mol Sci. 2023 Jan 10;24(2):1361. doi: 10.3390/ijms24021361.
Grade 1 chondrosarcoma of bone: a diagnostic and treatment dilemma.
Randall RL, Gowski W.
J Natl Compr Canc Netw. 2005 Mar;3(2):149-56. doi: 10.6004/jnccn.2005.0011.
Dedifferentiated chondrosarcoma.
Capanna R, Bertoni F, Bettelli G, Picci P, Bacchini P, Present D, Giunti A, Campanacci M.
J Bone Joint Surg Am. 1988 Jan;70(1):60-9.
Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma.
Gao Z, Lu T, Song H, Gao Z, Ren F, Ouyang P, Wang Y, Zhu J, Zhou S, He X.
Med Sci Monit. 2019 Nov 25;25:8952-8967. doi: 10.12659/MSM.917959.
